Related Experiment Video
Updated: Dec 28, 2025

Author Spotlight: Unlocking the Mysteries of Oral Potential Malignancies
Published on: August 11, 2023
Molecular landscape of salivary gland cancers
Ankita Kar1, Adegbola Adeniji1, Vishal U S Rao1
1Department of Head and Neck Oncology, Health Care Global Cancer Center, India.
Abstract:
Accurate diagnosis of salivary gland tumors can be challenging because of the many diagnostic entities, the sometimes extensive morphologic overlap, and the rarity of most tumor types. The current understanding of molecular rearrangements in salivary gland tumor pathology, emphasizes the prospects for exploiting molecular alterations in salivary gland tumors for diagnosis and targeted therapy. As new targeted therapies emerge, it will become increasingly vital to incorporate appropriate molecular testing into the pathologic evaluation of salivary gland cancers.
Insights
Diagnosing salivary gland tumors is complex due to overlapping features and rarity. Molecular testing offers new diagnostic and targeted therapy prospects for salivary gland cancers.
Area of Science:
- Oncology
- Pathology
- Molecular Biology
Background:
- Salivary gland tumor diagnosis presents challenges owing to numerous entities, morphologic overlap, and tumor rarity.
- Understanding molecular rearrangements is crucial for advancing salivary gland tumor pathology.
- Emerging targeted therapies necessitate integrating molecular testing into cancer evaluation.
Related Concept Videos
Salivary Glands and Saliva
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

